ABSTRACT
INTRODUCTION
In major depression, a diurnal variation in mood and a temporal alleviation of symptoms by the deprivation of sleep have often been observed. These clinical features gave rise to several hypotheses relating to the involvement of processes controlled by either the circadian pacemaker, the sleep-wake cycle or of an interaction between these processes in the dysregulation of mood (reviewed in for example Van den Hoofdakker 1994; Wirz-Justice 1995; Buysse et al 1999; Boivin 2000) . In the present experiment the regulation of mood in Seasonal Affective Disorder, winter type (SAD) is explored, specifically the contributions of the circadian pacemaker and the sleepwake cycle to this regulation.
The strongest evidence for the involvement of the duration of prior wakefulness in the regulation of mood has been found in sleep deprivation experiments. In depressed patients, sleep deprivation often results in a pronounced improvement while recovery sleep is followed by relapse (Wirz-Justice and Van den Hoofdakker 1999) . In contrast, healthy subjects experience a deterioration of mood when they are deprived of sleep (Gerner et al 1979; Brendel et al 1990) . Thus, the regulation of mood is at least affected by manipulation of the sleep-wake cycle in both depressed patients and controls.
Hypotheses about the involvement of a circadian factor in depression have especially gained interest for SAD. Like in non-seasonal depression, also in SAD both diurnal variation (Graw et al 1991; Krauss et al 1992) and a sleep deprivation-induced improvement of mood (Graw et al 1998) have been observed. The annual recurrence of depressive symptoms in autumn and/or winter (Rosenthal et al 1984) and the efficacy of bright light therapy (Terman et al 1989) provide additional support for the involvement of the circadian pacemaker in this disorder.
The human circadian pacemaker, localized in the suprachiasmatic nuclei of the brain, generates endogenous physiological and psychological rhythms with a near-24-hour period (Czeisler et al 1999) . The daily exposure to light, the pacemaker's most important Zeitgeber, synchronizes these endogenous circadian rhythms with the exogenous 24-hour light-dark cycle (Boivin et al 1996; Jewett et al 1997) . Thus, the pacemaker enables adequate adaptation to the alternation of light and darkness caused by the earth's rotation and is involved in the regulation of seasonal changes in behavior. It has been postulated that a phase delay of the circadian pacemaker relative to the timing of the sleep-wake cycle underlies the pathogenesis of SAD (Lewy et al 1987a) . According to the phase-delay hypothesis, light therapy applied in the morning is effective because of its phase-advancing properties. Alternatively, the amplitude hypothesis (Czeisler et al 1987) postulates that SAD patients might show a diminished circadian amplitude and that the amplitude enhancing effect of light applied in day time accounts for the efficacy of light therapy in SAD.
Overt circadian rhythms represent always a mixture of circadian and sleep-wakerelated processes. Constant routine-and forced desynchrony protocols have been designed to reveal unmasked circadian rhythms. In the constant routine (CR) protocol subjects are subjected to a regime of more than 24 hours of semi-recumbent wakefulness in dim light while hourly iso-caloric snacks provide a constant energy supply (Mills et al 1978; Czeisler et al 1985) . Physiological circadian rhythms measured under these constant conditions are considered to reflect unmasked circadian pacemaker activity. In a forced desynchrony (FD) protocol subjects are living on a schedule of artificial 'days' which are either shorter or longer than 24 hours, i.e., 20 or 28 hours (Kleitman and Kleitman 1953; Czeisler et al 1986) . In dim light, the circadian pacemaker is not able to adapt to this unusual schedule of wakefulness and sleep and starts to oscillate according to its endogenous period (Klerman et al 1996) . As a result of the desynchronization between the sleep-wake cycle and the circadian pacemaker, the scheduled activities occur at all endogenous circadian phase positions. Thus, the contributions of the sleep-wake cycle and the pacemaker to the circadian variation of a variable can be disentangled by a mathematical method (Dijk et al 1992; Hiddinga et al 1997) .
So far, two CR studies have been performed in female SAD patients and matched controls. In both studies, certain characteristics of the circadian rhythm in body temperature (Dahl et al 1993; Wirz-Justice et al 1995) melatonin (Dahl et al 1993) and cortisol (Avery et al 1997) were shown to be phase delayed in patients compared with those found in controls. After light therapy, a phase advance of some of the circadian temperature characteristics (Dahl et al 1993; Wirz-Justice et al 1995) and of the secretion of melatonin was observed (Dahl et al 1993) . Both studies did not reveal disturbances of circadian amplitude.
Besides a circadian variation in physiological variables, CR studies have also demonstrated a circadian modulation of mood in both healthy subjects and SAD patients (Wirz-Justice et al 1995; Monk et al 1997) . The CR-induced sleep deprivation affected the circadian mood variation in both groups differently. In the 40-hour CR study in which both SAD patients and controls participated, 52% of the patients and 29% of the controls showed an improvement of mood (Graw et al 1998) . Additionally, the circadian variation of 'well-being' measured in healthy subjects showed a declining linear trend in the course of a 36-hour CR protocol (Monk et al 1997) .
An obvious distinction between CR and FD protocols is that sleep deprivation effects are avoided by the latter. In FD protocols in healthy subjects, circadian and sleep-wake dependent influences on core body temperature have been shown (Hiddinga et al 1997; Czeisler et al 1999) . Moreover, a complex interaction between these two components has been demonstrated in many respects: the production of melatonin (Wyatt et al 1999) , the regulation of sleep (Dijk and Czeisler 1995; Wyatt et al 1999) , and the regulation of subjective alertness, cognitive performance (Dijk et al 1992) , and mood (Boivin et al 1997) . Like alertness and performance (Dijk et al 1992) , the circadian variation of mood was found to be closely associated with the circadian oscillation of core body temperature (Boivin et al 1997) . Mood respectively improves and worsens with the ascending and descending limbs of the endogenous circadian temperature curve, which reaches its minimum in the early morning. Additionally, mood was found to gradually deteriorate with the duration of prior wakefulness.
The aim of the present study was to investigate the contributions of the circadian pacemaker and the duration of prior wakefulness in the regulation of mood in SAD patients. Therefore, SAD patients were studied in a forced desynchrony protocol during a depressive episode, while recovered upon light treatment, and in summer. For comparison, also healthy matched control subjects were studied in winter and summer.
METHODS AND MATERIALS

Recruitment and Selection Criteria
SAD patients who in previous years responded favorably to morning bright light therapy administered at the outpatients clinic, received general written information about the study. Healthy controls were approached through local newspaper and television advertisements. Those who were interested received a detailed description of the protocol. If participation was considered, the study was verbally explained to all SAD patients and those controls that could be matched to one of the participating patients for age, sex, smoking habits and menstrual cycle phase (if appropriate). All subjects gave written informed consent and were paid for their participation. The study was approved by the Medical Ethics Committee of the Groningen Academic Hospital. Patients fulfilled the DSM-IV criteria for recurrent major depression with seasonal pattern (American Psychiatric Association 1994) and the Rosenthal criteria for SAD (Rosenthal et al 1984) . Controls had to have no psychopathological disturbances or sleeping problems.
To assess general mental health, depressive symptoms, seasonality and preference for morningness or eveningness, the following instruments were used: the General Health Questionnaire (GHQ; Goldberg and Williams 1988) (HRSD) and an 8-item atypical scale (ATYP) addressing atypical symptoms such as an increase in appetite and sleep. An M/E score below 30 and above 70 reflects evening-and morning types respectively. Controls required a score of below 3 on the GHQ, below 9 on the BDI and below 8 on the SIGH-SAD-SR as well as on the SPAQ (Kasper et al 1989) .
Subjects were physically fit, not dependent on alcohol or other substances and medication-free at least one month prior to participation (with the exception of the sporadic use of NSAIDs). Patients had not used psychoactive medications during at least six months before entering the study. Menstrual cycle phase was assessed through self-report. If appropriate, the use of oral contraceptives, a depot progesterone or estrogen-replacement therapy was continued.
During the winter season, depressive symptoms were monitored in patients by means of weekly BDI and SIGH-SAD-SR ratings. Patients were invited for participation during a depressive episode (BDI ≥ 16), when remitted after light therapy (BDI<6) and in summer. After finishing the protocol during the depressive episode, 45 minutes of 10,000 lux morning light therapy was administered at the out-patients clinic for at least 5 consecutive days. Controls participated in winter and in summer.
Subjects
From 1997 until 1999, the winter and summer experiments were scheduled during the months October -March and May -August respectively. In total, 7 SAD patients (1 male and 6 females) and 8 matched controls (1 male and 7 females) participated. Ages at the first participation, and scores on the GHQ, SPAQ and M/E questionnaire completed at the introduction meeting are summarized in Table 6 .1. After participating in summer, 1 female control subject canceled the second experiment and was therefore substituted by another matched control for the winter condition. In both groups, 3 subjects were cigarette smokers. Of the female patients, 4 were studied each time in the (pseudo-) follicular phase of their menstrual cycle and 1 in the pseudo-luteal phase. The participation of female controls was matched for menstrual cycle phase, except for the control subject matched to a post-menopausal patient participating in the pseudo-luteal phase while depressed and in the pseudo-follicular phase while remitted due to estrogen replacement therapy.
Protocol
The protocol took 10 days. For the first 4 days, subjects were instructed to restrict sleep to midnight till 8 AM, to refrain from daytime naps, heavy physical exercise and alcoholic beverages and to drink not more than 4 caffeine containing drinks a day. Table 6 .1 Characteristics of the subjects (mean ± SD): age (in years) at times of first participation, score on the General Health Questionnaire (GHQ), Seasonal Pattern Assessment Questionnaire (SPAQ) and Morningness/Eveningness questionnaire (M/E). For a more detailed description of these ratings see the method section. Severity of depression before and after finishing the forced desynchrony (FD) was assessed by the Beck Depression Inventory (BDI) and the Structured Interview Guide for the Hamilton Rating Scale for Depression -self-rating version (SIGH-SAD-SR) consisting of the 21-item Hamilton Rating Scale for Depression (HRSD) and an 8-item atypical symptom scale (ATYP). The period length (τ) of the circadian pacemaker (in minutes) was obtained from salivary melatonin assessed on day 4 and 9 of the protocol. The phase of the circadian pacemaker is expressed as the timing (hrs:min) of unmasked temperature minimum on the first morning in the time isolation unit. Seasonal Affective Disorder (SAD) patients participated during a depressive episode, remitted after light therapy and in summer. Controls participated once in winter and once in summer. Compliance to the regular sleep-wake schedule was verified by an actometer, which was continuously worn at the non-dominant wrist (Bakker and Beersma 1991). On day 4, subjects were admitted to the time isolation unit of the Psychiatry Department of the Groningen Academic Hospital. This facility comprises a small sound and light shielded apartment in which no information on time of day is available. A habituation period from 6 PM on day 4 till 8 AM on day 5 enabled the subjects to become acquainted with the experimental procedures during wakefulness and sleep. Sleep started at midnight. Subsequently, the participants were subjected to a 120-hour forced desynchrony protocol. Without knowledge of the timing of the experimental procedures, subjects were scheduled on six 20-hour days consisting of 13.5 hours of wakefulness in dim light (<10 lux) and 6.5 hours of darkness in which they had to be in bed. Staff members (conscious of revealing no information about time of day) had brief contacts with the subjects to announce the moments for rising, having meals, showering, performing psychometric tests, sticking electrodes for polysomnographic recordings and to announce the moments for going to bed. As a result, each subjective 20-hour day had the same temporal structure. Between the scheduled activities during wakefulness, subjects could watch videos, listen to music or perform other leisure activities according to their own preference. In the subjective morning a maximum intake of 4 caffeine containing drinks was permitted. Subjects were continuously monitored by an infra-red camera.
SAD
Melatonin and Core Body Temperature
For each experiment, phase position and period length of the circadian pacemaker were assessed from salivary melatonin and core body temperature data (chapter 4). While in time isolation, a continuously worn rectal probe connected to a portable device recorded core body temperature at 1-minute intervals (Bakker and Beersma 1991). Saliva was sampled hourly from 7 PM until midnight on day 4 and from 7 PM until 2 AM on day 9 of the protocol. Salivary melatonin concentrations were measured by radioimmunoassay (Bühlmann, Allschwill, Switzerland) and expressed as a percentage of the maximum melatonin value in the first sampling period (day 4). The dim light melatonin onset (DLMO) was defined as the time at which this normalized melatonin curve crossed the 25%-level. Temperature data showed that five circadian oscillations had passed between day 4 and 9. Therefore, an estimation of circadian period (τ) could be derived from the DLMO data. Circadian phase was derived from the circadian temperature cycle. This cycle was obtained by the following method, which is based on the assumption that body temperature is composed of the additive contribution of a sleep-wake-related and a pacemaker-related component. Body temperature data measured during the 20-hour subjective days were averaged and the obtained mean sleep wake related component was subtracted from the raw data. Next, the residual body temperature data were divided in epochs with the length of the computed τ-values and averaged. This procedure yields the mean circadian component of body temperature variation. Subsequently, this curve was subtracted from the raw data. This mathematical procedure was repeated until stable estimations of the endogenous and exogenous components were attained.
The phase of the circadian pacemaker was determined by transposing the data from the unmasked circadian temperature curve to the first circadian cycle in the time isolation unit. The timing of the minimum of this curve served as the reference phase (CT0). CT0 was assessed by computing the timing of the midpoint between the upward and downward crossings of the endogenous temperature curve through the mean, by means of a moving average procedure.
Mood Ratings
On day 1 and 10 of the protocol, subjects completed the BDI and SIGH-SAD-SR to evaluate the severity of depressive symptoms. During the baseline days at home, mood was rated three times daily. At 9:00 AM, 5:00 PM and 10:00 PM, subjects attributed a score between 1 and 10 to their mood (worst and best possible respectively) and completed the Adjective Mood Scale (AMS; Von Zerssen 1986) and a Visual Analogue Scale (VAS; Albersnagel 1987) for depression (VAS-D) and elation (VAS-E).
During wakefulness in the time isolation unit, these mood ratings were obtained at 2-hour intervals, the first of which 15 minutes after rising. The effects of the pacemaker and the sleep-wake cycle on mood were computed from the raw data by an iterative method. Like for the analysis of core body temperature, this method is based on the assumption that the raw course of mood is composed of the sum of these two components. First, mean mood scores were calculated as a function of duration of wakefulness. This initial estimation of the mean sleep-wake-related influence was subtracted from the original raw data points obtained during the 6 subjective days. Next, a circadian time was attributed to each resulting data point. This was done on the basis of the circadian phase and period length derived from temperature and melatonin data of the same experiment. The resulting curves were subsequently folded at the melatonin-derived τ-value to obtain an estimation of the mean circadian modulation of mood. Following the subtraction of the average pacemaker-related mood scores from the raw data points with similar circadian timing, the mean mood scores at specific times of the subjective day were calculated again to obtain a more accurate estimation of the influence of the duration of wakefulness on mood. After repeating the entire mathematical procedure 5 times, stable estimations of the effects of circadian phase and duration of wakefulness were established for each experiment.
Polysomnography
Since sleep deprivation induces changes of mood, each sleeping period in time isolation was evaluated by means of polysomnography (PSG). PSGs were recorded and visually scored according to the criteria of Rechtschaffen and Kales (1968) . This was done in 30-second intervals by three raters with the computerized aid of VitaPort software (TEMEC Instruments, Kerkrade, Netherlands). Raters displayed an average agreement with assigned scores of 95.4% (range 94.1% -96.3%), with an average largest disagreement interval of 3 minutes (range 1.5 -4 minutes). Total sleep time (TST) per scheduled sleeping period was calculated by adding the minutes in sleep stage 1, 2, 3, 4 and REM.
Statistical Analysis
The severity of depression before and after finishing the protocol, the sleep-wakeand pacemaker-related variations of mood and the respective TSTs obtained in forced desynchrony were evaluated by means of analysis of variance with repeated measures (ANOVA) to detect differences between patients and controls or between conditions. Paired t tests were used to analyze the circadian pacemaker characteristics and the amplitude of the sleep-wake cycle related and pacemaker-related modulation of mood. All statistical tests were performed two-tailed and significance was accepted at p < .05. Data on mood presented in figures were z-transformed to account for intersubject variability.
RESULTS
Severity of Depression before and after the 120-Hour Forced Desynchrony Experiment
The severity of depression before (day 1) and after the experiment (day 10) was assessed by the BDI and the SIGH-SAD-SR (Table 6 .1). On day 1, depressed SAD patients had a minimum score of 14 on the BDI and of 19 on the SIGH-SAD-SR, whereas in the other conditions for all subjects scores were less than 6 and less than 11 respectively. The BDI, the SIGH-SAD-SR and the 21-item HRSD sub-score exhibited a significant deterioration of mood after finishing the protocol (BDI: F(1,30) = 6.058, p = .020; SIGH-SAD-SR: F(1,30) = 14.710, p = .001; HRSD: F(1,30) = 23.710, p = .000)). This deterioration showed no significant difference between conditions (F(4,30) = 0.586, p = .675; F(4,30) = 2.084, p = .108 and F(4,30) = 0.687, p = .607 respectively). However, the 8-item ATYP did not show an overall significant effect of time (F(1,30) = 0.255, p = .617) and differed significantly between conditions (F(4,30) = 3.107, p = .030). Contrary to the other experimental conditions in which the atypical symptom score slightly increased, only in depressed patients the ATYP demonstrated a small decrease (i.e., improvement) over the experiment.
Chapter 6
Circadian Pacemaker Characteristics
The analysis of pacemaker characteristics (circadian period (τ), phase position and amplitude) from salivary melatonin and core body temperature data is described in detail in chapter 4. Table 6 .1 lists the observed average values for τ and phase of the circadian pacemaker for each condition. In patients and controls, melatonin-derived τ-values of slightly longer than 24 hours were observed in each condition. In both groups, the first unmasked circadian temperature minimum under time isolation occurred in the early morning of day 5. Paired t tests did not reveal significant differences in circadian pacemaker period and phase between patients and controls nor between conditions (df = 6, -1.760 < t < -0.375, p ≥ .129 and df = 6, -0.786 < t < 0.782, p ≥ .462 respectively). Figure 6 .1 illustrates the average course of mood during the waking hours of the 120 hour FD protocol assessed by means of the AMS.
Sleep-wake cycle related and pacemaker-related variations of mood
The average raw scores and the range of individual SD's (before the transformation to z-scores) of the AMS, the VAS-D, the VAS-E and the self-attributed mood scores obtained at 2-hour intervals during forced desynchrony are summarized in Table 6 .2. As expected, patients rated their mood significantly worse in the depressed state than when remitted and than in summer. The same holds for the comparison with controls in winter (paired samples tests for each of the three comparisons and four rating scales: df = 6, |t| > 2.853, p ≤ .029).
For each mood scale, the 42 consecutive raw scores were subjected to the iterative mathematical procedure described in the method section, to disentangle the influences of the sleep-wake cycle and the pacemaker on mood. A significant variation of mood as a function of time since awakening was revealed for the AMS (F(6,25) = 6.072, p = .001), the self-attributed mood score (F(6,25) = 4.474, p = .003) and the VAS-E (F(6,25) = 6.560, p = .000) which did not differ between conditions (AMS: .1 Course of mood in Seasonal Affective Disorder (SAD) patients and matched controls (mean ± SEM) as assessed by the Adjective Mood Scale, completed at 2-hour intervals during the entire 120-hour forced desynchrony protocol. The forced desynchrony protocol was composed of 6 20-hour days. Each 20-hour day consisted of 13.5 hours of wakefulness in dim light (<10 lux) and 6.5 hours of darkness, which had to be spent in bed (indicated by the shaded area). The AMS ranges from 0 (not depressed) -56 (severily depressed). Therefore negative z-scores represent better mood and are therefore plotted at higher levels. Patients participated during a depressive episode, remitted after light therapy and in summer. Controls participated once in winter and once in summer. Figure 6 .2 depicts the average course of the AMS scores per condition both as a function of time since awakening and of circadian time. In each condition, the sleep wake related variation of mood shows an improvement during the first four hours of wakefulness. Thereafter, mood gradually deteriorates. Only in the depressed patients mood improves just before bedtime. The pacemaker-related variation in mood shows an almost sinusoidal course in each condition. In healthy subjects, the circadian variation of mood has been found to parallel the circadian variation of body temperature (Boivin et al 1997) . Therefore, in Figure 6 .2, the sleep-wake cycle-related and the pacemaker related variations in core body temperature are plotted. Since the pacemaker's period length and phase position did not differ between conditions, the temperature data were averaged across all forced desynchrony experiments. The sleep-wake Table 6 .2 Mood ratings during the forced desynchrony experiment in Seasonal Affective Disorder (SAD) patients and matched controls. Scores on the Adjective Mood Scale (AMS) range from 0 (not depressed) -56 (severely depressed), scores on the Visual Analogue Scale for Depression (VAS-D) and on the Visual Analogue Scale for Elation (VAS-E) both range from 0 (not at all depressed/elated) -100 (extremely depressed/elated). The self attributed mood score consists of a score ranging from 0 -10 (worst and best possible respectively). Of each rating, the mean (and SD) of all ratings is computed by averaging the 42 scores obtained throughout the 120-hour forced desynchrony protocol. The range of individual SDs is indicated as well.
SAD patients controls depressed remitted summer winter summer (n = 7) (n = 7) (n = 7) (n = 7) (n = 7) AMS Mean of all ratings 31.9±10.6 9.9±4.4 10.3±6.2 5.9±2.7 8.5±3.0 Range of individual SDs 6.8-17.6 1.4-10.2 1.0-14.3 1.2-9.1 1.5-8.6
Self-attributed mood score Mean of all ratings 5.3±0.9 7.3±0. .2 Sleep-wake cycle related and pacemaker-related modulation of mood and core body temperature (mean ± SEM) in Seasonal Affective Disorder (SAD) patients and matched controls. The ztransformed data on the circadian and sleep-wake related components of mood were calculated from the Adjective Mood Scale (AMS), completed at 2-hour intervals during wakefulness in forced desynchrony. Negative scores represent better mood. The shaded area indicates the period for sleep. Throughout the protocol, core body temperature was measured at 1-minute intervals. The temperature data are averaged across all forced desynchrony experiments. Patients participated during a depressive episode, remitted after light therapy and in summer. Controls participated once in winter and once in summer.
cycle related variation of body temperature shows an increase in temperature after waking up, with a sharp peak induced by showering. After a subsequent drop, the temperature level remains relatively stable during the remaining hours of wakefulness. Finally, at the start of the sleeping period, a decrease in temperature can be observed. The pacemaker related variation of body temperature has a sinusoidal shape. CT0 refers to the timing of the circadian temperature minimum (see Table  6 .1). The pacemaker-related variation in mood runs parallel with the circadian temperature curve, with an improvement of mood when the curve rises and a worsening when it descends.
Reconstruction of the Daily Course of Mood
To investigate whether the average course of mood during the baseline days could be explained from the two factors involved in mood regulation, a circadian time was assigned to the baseline ratings based on the pacemaker's phase. Mood at baseline was reconstructed by adding those values of both components that closely fitted the respective duration of wakefulness and circadian phase for each 2-hour interval starting from 9 AM. Figure 6 .3 depicts the average course of the AMS ratings both as collected at home and as reconstructed on the basis of the two components for each condition. The daily course of mood at baseline was calculated by averaging the values of 9:00 AM, 5:00 PM and 10:00 PM in the interval between 5:00 PM on day 1 until 9:00 AM on day 4. In each condition, the reconstructed course of mood closely follows the average course of mood at baseline.
Effect of Forced Desynchrony on Sleep
Sleep deprivation can have effects on mood. Hence, TST was determined for each subjective night in forced desynchrony (Table 6 .3). A significant effect of night sequence number in forced desynchrony on TST was observed when the data of all conditions were combined (ANOVA: F(5,26) = 6.872, p = .000. However, no significant interaction between night number and condition was detected (F(20,116) = 0.667, p = .851). Additionally, separate ANOVAs to compare the various conditions in which patients and controls were studied did not reveal significant differences either. 
DISCUSSION
Recently, an FD study in healthy subjects has demonstrated that two factors influence mood by means of a complex non-additive interaction: a circadian factor and the duration of wakefulness (Boivin et al 1997) . Several clinical features of affective disorders (reviewed in for example Wirz-Justice 1995; Boivin 2000) also suggest an involvement of these two factors in the regulation of mood. The aim of the present study was to explore the contributions of the sleep-wake cycle and the circadian pacemaker to the regulation of mood in SAD patients. Up to date, only few studies of mood in depressed patients isolated from time cues have been performed. In one of these studies a male patient with 48-hour manic depressive mood cycles was subjected to twelve 22-hour days (Jenner et al 1968) . The period length of the otherwise remarkably regular 48-hour mood cycles changed to 44 hours. It was concluded that the environment, and not a 'metabolic clock' within the patient, is important in the regulation of mood. However, from a free-run experiment in another male patient with 48-hour unipolar depressive cycles the opposite was concluded (Dirlich et al 1981) . That study showed that the circadian organization of mood remained unaffected under time isolation, while the duration of the restactivity cycle shortened to approximately 19.5 hours. Finally, in a third study three female manic-depressives and one female unipolar depressive patient were isolated from time cues for 3-4 weeks (Wehr et al 1985) . In none of these patients the clinical state remained stable. It was hypothesized that the clinical instability might have Patients (depressed; n = 7) 322±75 279±97 310±69 316±81 356±43 356±5 Patients (remitted; n = 7) 346±39 314±75 319±47 302±71 349±34 351±21 Patients (summer; n = 7) 352±12 308±82 308±60 336±41 334±36 362±13 Controls (winter; n = 7) 347±33 326±49 311±65 348±41 339±38 356±15 Controls (summer; n = 7) 349±25 289±66 315±66 338±52 332±54 359±24
resulted from changes of phase relationships between the circadian pacemaker and the sleep wake cycle. It may be concluded from these studies that the contributions of the sleep wake cycle and the pacemaker to the regulation of mood in depression
were not yet elucidated. The aim of the present FD study was to assess the contributions of the pacemaker and the sleep-wake cycle to the variation of mood in SAD patients and matched controls. The data show that the influences of the pacemaker and the sleep-wake cycle on mood in SAD patients do not differ form those in healthy subjects. In all conditions, the protocol was tolerated quite well and did not induce strong lasting effects on mood in patients nor controls. Scores on the BDI and the SIGH-SAD-SR completed prior to and directly following the 10-day protocol revealed that the experiment induced only a small deterioration of mood in both groups.
There were changes of mood during the protocol: the course of self-rated mood varied across the consecutive periods of wakefulness in each condition (Figure 6 .1). Sleep recordings were examined to test whether sleep duration influenced mood. The PSG data showed that the protocol affected TST similarly in patients and controls (Table 6. 3). Average TST was shortest in the second period for sleep in FD, scheduled from 5:45 PM until 0:15 AM. This corresponds with the data of another FD study in which healthy subjects were scheduled on 20-hour subjective days (Wyatt et al 1999) , which observed that sleep was most disrupted when centered around CT16 (which approximates 9:00 PM in the present study). Comparison of mood scores before and after the night with shortest TST reveals a slight (but non-significant) deterioration of mood in the depressed patients. Since in depression sleep deprivation on average induces a mood improvement, sleep deprivation effects do not explain the observed variation of mood.
Like in the FD study in healthy subjects (Boivin et al 1997) , the present study shows both sleep-wake cycle-and pacemaker-related components in the variation of mood, which were not significantly different between patients and controls. For three of the four mood scales the observed circadian and sleep-wake related modulation reached significance. Differences in the composition of the four rating scales used are a likely explanation for differences observed between these questionnaires. Following the first four hours of wakefulness in which mood was found to improve, in all conditions a subsequent worsening was observed with increasing duration of wakefulness. The circadian variation of mood in turn closely followed the sinusoidal circadian variation in core body temperature in all conditions. The observed minimum mood scores were centered near the circadian temperature minimum, which occurs in the early morning under entrained conditions. Unfortunately, due to the restricted length of the design the possibility of differences in interaction between the two components (Boivin et al 1997) could not be studied. For each condition, the recon-struction of the daily variation of mood by means of addition of the two components closely followed the average mood scores obtained at 9:00 AM, 5:00 PM and 10:00 PM during baseline.
The present study does not support the notion of an abnormal impact of the pacemaker on both psychological and physiological variables in SAD. Comparisons between SAD patients and controls revealed no significant differences in period or phase of the pacemaker assessed by salivary melatonin and the endogenous circadian variation in core body temperature. Contrary to previous constant routine studies (Dahl et al 1993; Wirz-Justice et al 1995; Avery et al 1997) , these results, discussed in detail in chapter 4, suggest that a disturbance of the circadian pacemaker is not likely to be involved in the pathogenesis of SAD. However, the present results might contribute to a better understanding of the mechanisms underlying the beneficial effects of light therapy. Although some studies have concluded that the timing of light therapy is not crucial (Wirz-Justice et al 1993; Meesters et al 1995) , most studies report a superiority of morning light over evening light (e.g. Lewy et al 1998; Terman et al 2001) . From circadian studies in healthy subjects it is clear that morning light advances the circadian pacemaker (Honma and Honma 1988; Czeisler et al 1989; Minors et al 1991; Jewett et al 1997) . It has also been observed that shifts of the pacemaker are accompanied by proportional shifts in psychological variables such as subjective alertness and cognitive performance (Czeisler et al 1990) . Thus, morning light therapy in SAD will not only phase-advance the pacemaker but also the rising limb of the pacemaker-related mood variation. Therefore, the rising part of the circadian mood variation will shift to an earlier clock time and might even occur during sleep. As a result, morning light therapy in SAD patients might provide a better mood at awakening.
